Cargando…
ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolites
Nucleosides represent a major chemotherapeutic class for treating cancer, however their limitations in terms of cellular uptake, nucleoside kinase-mediated activation and catabolism are well-documented. The monophosphate pro-nucleotides known as ProTides represents a powerful strategy for bypassing...
Autores principales: | Kandil, Sahar, Balzarini, Jan, Rat, Stephanie, Brancale, Andrea, Westwell, Andrew D., McGuigan, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131913/ https://www.ncbi.nlm.nih.gov/pubmed/27818111 http://dx.doi.org/10.1016/j.bmcl.2016.10.077 |
Ejemplares similares
-
Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin
por: Derudas, Marco, et al.
Publicado: (2010) -
Radiosynthesis of [(18)F]-Labelled Pro-Nucleotides (ProTides)
por: Cavaliere, Alessandra, et al.
Publicado: (2020) -
Design, synthesis and biological evaluation of 2′-deoxy-2′,2′-difluoro-5-halouridine phosphoramidate ProTides
por: Quintiliani, Maurizio, et al.
Publicado: (2011) -
Microwave-assisted organic synthesis of nucleoside ProTide analogues
por: Bordoni, Cinzia, et al.
Publicado: (2019) -
The ProTide Prodrug
Technology: From the Concept to
the Clinic: Miniperspective
por: Mehellou, Youcef, et al.
Publicado: (2017)